Rivaroxaban:a direct factor Xa inhibitor for VTE prophylaxis in patients undergoing total knee or hip replacement surgery.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2009 AND VI 44 AND IP 8
Results: 14
1
2
Emerging risk factors and risk markers for cardiovascular disease: looking beyond NCEP ATP III.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
3
Drug watch. Osteoarthritis and acute/chronic pain.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
4
IVIg treatment associated with a reduced risk of Alzheimer's disease.
- Published in:
- 2009
- Publication type:
- Journal Article
5
First-time generic approval.
- Published in:
- 2009
- Publication type:
- Journal Article
6
FDA actions in brief.
- Published in:
- 2009
- Publication type:
- Journal Article
7
New molecular entities.
- Published in:
- Formulary, 2009, v. 44, n. 8, p. 223
- Publication type:
- Article
8
Osteoarthritis and acute/chronic pain.
- Published in:
- Formulary, 2009, v. 44, n. 8, p. 248
- Publication type:
- Article
9
Rivaroxaban: A direct factor Xa inhibitor for VTE prophylaxis in patients undergoing total knee or hip replacement surgery.
- Published in:
- Formulary, 2009, v. 44, n. 8, p. 226
- By:
- Publication type:
- Article
10
IVIg treatment associated with a reduced risk of Alzheimer's disease.
- Published in:
- Formulary, 2009, v. 44, n. 8, p. 225
- Publication type:
- Article
11
FDA actions in brief.
- Published in:
- Formulary, 2009, v. 44, n. 8, p. 224
- Publication type:
- Article
12
First-time generic approval.
- Published in:
- Formulary, 2009, v. 44, n. 8, p. 224
- Publication type:
- Article
13
Emerging risk factors and risk markers for cardiovascular disease: Looking beyond NCEP ATP.
- Published in:
- Formulary, 2009, v. 44, n. 8, p. 237
- By:
- Publication type:
- Article
14
Pipeline preview.
- Published in:
- Formulary, 2009, v. 44, n. 8, p. 223
- Publication type:
- Article